Behnaz Farhang, MD
Internal Medicine · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Hospitals listed: 057545 · 557073 · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Farhang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A166906 · Current
Licensed to practise in California · since 2019 · expires 2027-11-30 · Islamic Azad University, Tehran Medical Branch.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$83,117
Medicare paid this office $83,117 for 207 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 188 | $38,881 | $91 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $16,154 | $137 |
| Long return visit (40+ min) | 66 | $12,810 | $132 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,185 | $290 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 99 | $2,109 | $13 |
See all 9 services
| Return visit (30+ min) | 188 | $38,881 | $91 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $16,154 | $137 |
| Long return visit (40+ min) | 66 | $12,810 | $132 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,185 | $290 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 99 | $2,109 | $13 |
| Influenza vaccine, inactivated | 11 | $900 | $82 |
| Short return visit (20+ min) | 13 | $690 | $53 |
| Administration of influenza virus vaccine | 18 | $615 | $34 |
| Administration of pneumococcal vaccine | 13 | $444 | $34 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
207 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 16% · Women 67% · Also on Medicaid 10% · Health risk score 1.16. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 68% · Diabetes 29% · Chronic kidney disease 28% · Depression 27% · Coronary heart disease 20% · Cancer 18% · Atrial fibrillation 18% · Heart failure 14% · COPD 12% · Dementia 7% · Stroke 5%.
The office billed $294,853, Medicare allowed $109,338 and paid $83,117; for 1,068 services of 48 kinds; $5,873 of it was for drugs given in the office and $77,244 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 207 | 1,068 | 76 | 1.16 | $294,853 | $83,117 |
| 2023 | 200 | 1,087 | 76 | 1.14 | $279,859 | $85,587 |
| 2022 | 166 | 795 | 75 | 1.08 | $191,460 | $59,811 |
| 2021 | 161 | 738 | 75 | 1.08 | $151,163 | $44,574 |
| 2020 | 85 | 144 | 75 | 0.98 | $35,125 | $10,724 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 182 | $43,010 | $95 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 109 | $15,088 | $138 |
| Long return visit (40+ min) | 45 | $9,180 | $146 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 27 | $2,041 | $76 |
| Short return visit (20+ min) | 18 | $1,263 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,048 | $95 |
| Administration of influenza virus vaccine | 30 | $989 | $33 |
| Aspiration and/or injection of fluid from large joint | 13 | $966 | $60 |
| Administration of pneumococcal vaccine | 12 | $395 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $323 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $132 | None |
2022: 10 services
| Return visit (30+ min) | 130 | $27,598 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 81 | $11,237 | $139 |
| Long return visit (40+ min) | 44 | $7,506 | $132 |
| Short return visit (20+ min) | 31 | $2,349 | $65 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 19 | $1,335 | $70 |
| Aspiration and/or injection of fluid from large joint | 15 | $1,153 | $55 |
| Administration of influenza virus vaccine | 20 | $631 | $32 |
| Administration of pneumococcal vaccine | 14 | $445 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $290 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $105 | None |
2021: 9 services
| Return visit (30+ min) | 113 | $23,300 | $96 |
| Long return visit (40+ min) | 46 | $7,922 | $124 |
| Short return visit (20+ min) | 61 | $4,777 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,922 | $139 |
| Influenza vaccine split virus, preservative free | 15 | $979 | $65 |
| Aspiration and/or injection of fluid from large joint | 12 | $809 | $58 |
| Administration of influenza virus vaccine | 16 | $288 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $237 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $191 | None |
2020: 3 services
| Return visit (30+ min) | 52 | $5,342 | $88 |
| Long return visit (40+ min) | 14 | $1,907 | $127 |
| Short return visit (20+ min) | 21 | $1,218 | $51 |
Drugs they prescribed that Part D paid
$772,256
Pharmacies billed $772,256 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (234 of 6,953) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 11% of their opioid prescriptions.
6,004 generic and 892 brand-name prescriptions · $772,256 in drug cost · 101 antibiotic prescriptions to 64 people · 35 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 127 | $177,985 | $1,401 |
| Eliquis | 67 | $92,732 | $1,384 |
| Trulicity | 23 | $41,065 | $1,785 |
| Jardiance | 40 | $39,205 | $980 |
| Rybelsus | 16 | $36,991 | $2,312 |
See all 126 drugs
| Ozempic | 127 | $177,985 | $1,401 |
| Eliquis | 67 | $92,732 | $1,384 |
| Trulicity | 23 | $41,065 | $1,785 |
| Jardiance | 40 | $39,205 | $980 |
| Rybelsus | 16 | $36,991 | $2,312 |
| Farxiga | 14 | $22,426 | $1,602 |
| Tresiba Flextouch U-100 | 24 | $11,355 | $473 |
| Bydureon Bcise | 11 | $8,957 | $814 |
| Basaglar Kwikpen U-100 | 17 | $7,667 | $451 |
| Symbicort | 14 | $7,190 | $514 |
| Atorvastatin | 489 | $5,719 | $12 |
| Humalog Kwikpen U-100 | 23 | $5,365 | $233 |
| Gabapentin | 239 | $4,666 | $20 |
| Breo Ellipta | 12 | $4,666 | $389 |
| Hydrocodone-Acetaminophen | 146 | $4,577 | $31 |
| Levothyroxine | 255 | $3,920 | $15 |
| Fluticasone-Salmeterol | 23 | $3,683 | $160 |
| Synthroid | 45 | $3,570 | $79 |
| Estradiol | 23 | $3,010 | $131 |
| Lantus Solostar | 25 | $2,700 | $108 |
| Duloxetine | 94 | $2,630 | $28 |
| Amlodipine Besylate | 324 | $2,512 | $8 |
| Pantoprazole | 165 | $2,436 | $15 |
| Losartan | 190 | $2,381 | $13 |
| Lantus | 19 | $2,370 | $125 |
| Potassium Chloride | 157 | $2,190 | $14 |
| Fluticasone Propionate | 86 | $2,149 | $25 |
| Ezetimibe | 53 | $2,034 | $38 |
| Diclofenac | 35 | $1,928 | $55 |
| Metoprolol | 134 | $1,789 | $13 |
| Insulin Lispro Kwikpen U-100 | 12 | $1,783 | $149 |
| Lisinopril | 219 | $1,771 | $8 |
| Famotidine | 79 | $1,739 | $22 |
| Lidocaine | 12 | $1,703 | $142 |
| Mirtazapine | 65 | $1,567 | $24 |
| Pregabalin | 39 | $1,530 | $39 |
| Omeprazole | 76 | $1,412 | $19 |
| Carbamazepine | 19 | $1,411 | $74 |
| Pravastatin | 68 | $1,326 | $19 |
| Tamsulosin | 80 | $1,294 | $16 |
| Metformin Hcl Er | 122 | $1,221 | $10 |
| Albuterol Sulfate Hfa | 54 | $1,198 | $22 |
| Methadone | 22 | $1,177 | $54 |
| Valacyclovir | 18 | $1,133 | $63 |
| Rosuvastatin | 62 | $1,107 | $18 |
| Alendronate | 113 | $1,101 | $10 |
| Simvastatin | 76 | $1,036 | $14 |
| Wixela Inhub | 11 | $1,033 | $94 |
| Verapamil Sr | 13 | $1,028 | $79 |
| Azelastine | 24 | $1,023 | $43 |
| Memantine | 22 | $977 | $44 |
| Cyclobenzaprine | 74 | $971 | $13 |
| Bupropion Xl | 49 | $954 | $19 |
| Trazodone | 82 | $951 | $12 |
| Escitalopram | 59 | $921 | $16 |
| Irbesartan | 22 | $832 | $38 |
| Metformin | 89 | $800 | $9 |
| Nano 2nd Gen Pen Needle | 16 | $777 | $49 |
| Valsartan | 17 | $734 | $43 |
| Fluoxetine | 34 | $714 | $21 |
| Ipratropium | 11 | $676 | $61 |
| Clopidogrel | 42 | $671 | $16 |
| Ciprofloxacin | 12 | $671 | $56 |
| Aripiprazole | 25 | $639 | $26 |
| Felodipine Er | 15 | $633 | $42 |
| Bumetanide | 12 | $600 | $50 |
| Citalopram Hbr | 44 | $599 | $14 |
| Buprenorphine-Naloxone | 17 | $597 | $35 |
| Bupropion | 12 | $591 | $49 |
| Sertraline | 56 | $589 | $11 |
| Hydralazine | 33 | $587 | $18 |
| Furosemide | 129 | $586 | $5 |
| Celecoxib | 29 | $581 | $20 |
| Isosorbide Mononitrate Er | 14 | $570 | $41 |
| Triamterene-Hydrochlorothiazid | 47 | $528 | $11 |
| Metoprolol | 43 | $526 | $12 |
| Acyclovir | 14 | $524 | $37 |
| Amitriptyline | 18 | $498 | $28 |
| Buspirone | 19 | $466 | $25 |
| Montelukast | 39 | $459 | $12 |
| Spironolactone | 44 | $446 | $10 |
| Venlafaxine Hcl Er | 23 | $410 | $18 |
| Galantamine Hbr | 13 | $408 | $31 |
| Carvedilol | 31 | $403 | $13 |
| Triamcinolone Acetonide | 39 | $392 | $10 |
| Paroxetine | 23 | $380 | $17 |
| Diltiazem 24hr Er (Cd) | 14 | $380 | $27 |
| Prazosin | 19 | $359 | $19 |
| Omega-3 Acid Ethyl Esters | 13 | $351 | $27 |
| Pramipexole Dihydrochloride | 11 | $349 | $32 |
| Hydroxyzine | 29 | $323 | $11 |
| Ciclopirox | 12 | $322 | $27 |
| Glipizide Er | 40 | $311 | $8 |
| Benazepril | 12 | $302 | $25 |
| Ropinirole | 15 | $299 | $20 |
| Donepezil | 23 | $288 | $13 |
| Ketoconazole | 15 | $287 | $19 |
| Baclofen | 27 | $279 | $10 |
| Finasteride | 22 | $268 | $12 |
| Warfarin | 25 | $257 | $10 |
| Prochlorperazine Maleate | 12 | $243 | $20 |
| Allopurinol | 25 | $238 | $10 |
| Propranolol | 13 | $234 | $18 |
| Lisinopril-Hydrochlorothiazide | 14 | $234 | $17 |
| Nystatin | 12 | $225 | $19 |
| Topiramate | 13 | $219 | $17 |
| Clonidine | 21 | $207 | $10 |
| Oxycodone-Acetaminophen | 17 | $195 | $11 |
| Sumatriptan | 24 | $176 | $7 |
| Atenolol | 19 | $155 | $8 |
| Zolpidem | 53 | $152 | $3 |
| Hydrochlorothiazide | 32 | $146 | $5 |
| Amoxicillin-Clavulanate Potass | 15 | $128 | $9 |
| Glipizide | 19 | $98 | $5 |
| Oxycodone | 14 | $95 | $7 |
| Ibuprofen | 12 | $93 | $8 |
| Alprazolam | 25 | $92 | $4 |
| Oxybutynin Chloride Er | 12 | $90 | $7 |
| Diazepam | 16 | $88 | $5 |
| Tramadol | 32 | $86 | $3 |
| Temazepam | 21 | $73 | $3 |
| Fluconazole | 13 | $44 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $37 | $2 |
| Prednisone | 21 | $26 | $1 |
| Lorazepam | 27 | $11 | $0 |
| Paxlovid | 12 | $0 | $0 |
Year by year
| 2024 | 6,953 | 480 | 3% (234) | 13% | $772,256 |
| 2023 | 6,364 | 426 | 4% (229) | 13% | $855,441 |
| 2022 | 6,109 | 401 | 4% (253) | 12% | $607,222 |
| 2021 | 4,635 | 364 | 7% (313) | 11% | $454,812 |
| 2020 | 356 | 141 | 8% (28) | None | $32,876 |
| 2019 | 25 | 15 | 0% (0) | None | $3,050 |
| 2018 | 99 | 39 | None | 19% | $5,326 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 119 drugs
| Ozempic | 147 | $184,833 | $1,257 |
| Eliquis | 87 | $96,394 | $1,108 |
| Trulicity | 54 | $67,888 | $1,257 |
| Rybelsus | 24 | $46,892 | $1,954 |
| Jardiance | 24 | $32,647 | $1,360 |
| Lantus Solostar | 41 | $22,921 | $559 |
| Symbicort | 23 | $14,823 | $644 |
| Humalog Kwikpen U-100 | 17 | $13,246 | $779 |
| Invokana | 14 | $13,110 | $936 |
| Flovent Hfa | 23 | $11,907 | $518 |
| Tresiba Flextouch U-100 | 16 | $9,458 | $591 |
| Trelegy Ellipta | 12 | $9,147 | $762 |
| Atorvastatin | 370 | $6,815 | $18 |
| Diclofenac | 81 | $6,403 | $79 |
| Hydrocodone-Acetaminophen | 143 | $5,868 | $41 |
| Lantus | 14 | $5,593 | $399 |
| Gabapentin | 220 | $5,158 | $23 |
| Losartan | 195 | $4,502 | $23 |
| Levothyroxine | 207 | $4,078 | $20 |
| Pantoprazole | 178 | $3,768 | $21 |
| Potassium Chloride | 170 | $3,283 | $19 |
| Metoprolol | 125 | $3,126 | $25 |
| Fluticasone Propionate | 90 | $2,735 | $30 |
| Amlodipine Besylate | 278 | $2,609 | $9 |
| Duloxetine | 96 | $2,587 | $27 |
| Ezetimibe | 48 | $2,444 | $51 |
| Synthroid | 21 | $2,308 | $110 |
| Tamsulosin | 102 | $2,275 | $22 |
| Lisinopril | 216 | $2,174 | $10 |
| Simvastatin | 69 | $1,558 | $23 |
| Pravastatin | 53 | $1,503 | $28 |
| Buspirone | 37 | $1,477 | $40 |
| Clopidogrel | 51 | $1,471 | $29 |
| Hydralazine | 37 | $1,395 | $38 |
| Metformin Hcl Er | 97 | $1,391 | $14 |
| Carbamazepine | 13 | $1,378 | $106 |
| Omeprazole | 68 | $1,338 | $20 |
| Methadone | 23 | $1,311 | $57 |
| Ultra-Fine Short Pen Needle | 12 | $1,296 | $108 |
| Metformin | 85 | $1,282 | $15 |
| Estradiol | 15 | $1,234 | $82 |
| Rosuvastatin | 33 | $1,224 | $37 |
| Mirtazapine | 38 | $1,208 | $32 |
| Triamterene-Hydrochlorothiazid | 56 | $1,116 | $20 |
| Famotidine | 53 | $1,115 | $21 |
| Metoprolol | 45 | $1,058 | $24 |
| Alendronate | 79 | $1,010 | $13 |
| Cyclobenzaprine | 53 | $1,006 | $19 |
| Albuterol Sulfate Hfa | 46 | $1,001 | $22 |
| Fluoxetine | 30 | $982 | $33 |
| Irbesartan | 12 | $977 | $81 |
| Bupropion Xl | 38 | $908 | $24 |
| Spironolactone | 32 | $893 | $28 |
| Bumetanide | 19 | $886 | $47 |
| Glipizide Er | 40 | $872 | $22 |
| Carvedilol | 37 | $869 | $23 |
| Furosemide | 122 | $843 | $7 |
| Montelukast | 40 | $818 | $20 |
| Hydroxyzine | 29 | $806 | $28 |
| Felodipine Er | 11 | $805 | $73 |
| Lamotrigine | 16 | $747 | $47 |
| Ciclopirox | 16 | $727 | $45 |
| Ventolin Hfa | 11 | $691 | $63 |
| Trazodone | 72 | $670 | $9 |
| Azelastine | 16 | $667 | $42 |
| Nano 2nd Gen Pen Needle | 14 | $663 | $47 |
| Warfarin | 20 | $638 | $32 |
| Ketoconazole | 21 | $628 | $30 |
| Galantamine Hbr | 11 | $623 | $57 |
| Sertraline | 41 | $607 | $15 |
| Glipizide | 34 | $598 | $18 |
| Donepezil | 14 | $577 | $41 |
| Allopurinol | 31 | $570 | $18 |
| Citalopram Hbr | 34 | $554 | $16 |
| Escitalopram | 37 | $542 | $15 |
| Insulin Lispro | 11 | $538 | $49 |
| Diltiazem 24hr Er (Cd) | 15 | $532 | $35 |
| Isosorbide Mononitrate Er | 13 | $515 | $40 |
| Ropinirole | 14 | $505 | $36 |
| Digoxin | 19 | $483 | $25 |
| Triamcinolone Acetonide | 48 | $439 | $9 |
| Venlafaxine Hcl Er | 13 | $415 | $32 |
| Amitriptyline | 19 | $411 | $22 |
| Atenolol | 20 | $378 | $19 |
| Paroxetine | 18 | $376 | $21 |
| Lisinopril-Hydrochlorothiazide | 26 | $374 | $14 |
| Oxybutynin Chloride Er | 12 | $369 | $31 |
| Acyclovir | 12 | $356 | $30 |
| Celecoxib | 13 | $355 | $27 |
| Cephalexin | 21 | $334 | $16 |
| Latanoprost | 11 | $327 | $30 |
| Nortriptyline | 18 | $301 | $17 |
| Hydrochlorothiazide | 37 | $273 | $7 |
| Prochlorperazine Maleate | 13 | $262 | $20 |
| Tizanidine | 14 | $252 | $18 |
| Pregabalin | 17 | $249 | $15 |
| Quetiapine | 15 | $237 | $16 |
| Oxycodone-Acetaminophen | 21 | $226 | $11 |
| Zolpidem | 36 | $216 | $6 |
| Finasteride | 14 | $206 | $15 |
| Butalbital-Acetaminophen-Caffe | 11 | $203 | $18 |
| Tramadol | 29 | $199 | $7 |
| Vitamin D2 | 19 | $188 | $10 |
| Benazepril | 12 | $166 | $14 |
| Oxycodone | 11 | $166 | $15 |
| Propranolol | 13 | $164 | $13 |
| Ondansetron | 11 | $151 | $14 |
| Clonazepam | 18 | $145 | $8 |
| Amoxicillin-Clavulanate Potass | 14 | $141 | $10 |
| Ibuprofen | 16 | $137 | $9 |
| Alprazolam | 24 | $132 | $5 |
| Folic Acid | 24 | $130 | $5 |
| Sumatriptan | 18 | $127 | $7 |
| Prednisone | 15 | $88 | $6 |
| Diazepam | 23 | $88 | $4 |
| Sulfamethoxazole-Trimethoprim | 15 | $80 | $5 |
| Azithromycin | 13 | $46 | $4 |
| Eszopiclone | 11 | $38 | $3 |
| Lorazepam | 20 | $29 | $1 |
2022: 120 drugs
| Ozempic | 112 | $112,915 | $1,008 |
| Eliquis | 75 | $70,543 | $941 |
| Rybelsus | 25 | $27,167 | $1,087 |
| Jardiance | 24 | $25,478 | $1,062 |
| Lantus Solostar | 36 | $21,675 | $602 |
| Trulicity | 18 | $17,007 | $945 |
| Invokana | 12 | $15,065 | $1,255 |
| Myrbetriq | 17 | $11,671 | $687 |
| Farxiga | 11 | $11,141 | $1,013 |
| Flovent Hfa | 21 | $8,627 | $411 |
| Advair Diskus | 14 | $8,518 | $608 |
| Lantus | 17 | $7,280 | $428 |
| Atorvastatin | 353 | $5,377 | $15 |
| Hydrocodone-Acetaminophen | 154 | $5,372 | $35 |
| Gabapentin | 178 | $5,215 | $29 |
| Levothyroxine | 193 | $4,286 | $22 |
| Diclofenac | 76 | $3,580 | $47 |
| Potassium Chloride | 141 | $3,321 | $24 |
| Pantoprazole | 175 | $3,227 | $18 |
| Losartan | 203 | $3,153 | $16 |
| Duloxetine | 103 | $3,129 | $30 |
| Levemir Flextouch | 13 | $3,057 | $235 |
| Metoprolol | 132 | $2,819 | $21 |
| Albuterol Sulfate Hfa | 69 | $2,679 | $39 |
| Bumetanide | 37 | $2,444 | $66 |
| Tamsulosin | 116 | $2,438 | $21 |
| Synthroid | 27 | $2,204 | $82 |
| Fluticasone Propionate | 74 | $1,939 | $26 |
| Omeprazole | 77 | $1,647 | $21 |
| Metoprolol | 58 | $1,599 | $28 |
| Ezetimibe | 36 | $1,574 | $44 |
| Cyclobenzaprine | 86 | $1,515 | $18 |
| Amlodipine Besylate | 221 | $1,482 | $7 |
| Lisinopril | 212 | $1,379 | $7 |
| Carbamazepine | 12 | $1,336 | $111 |
| Metformin Hcl Er | 89 | $1,300 | $15 |
| Triamterene-Hydrochlorothiazid | 60 | $1,297 | $22 |
| Clopidogrel | 50 | $1,293 | $26 |
| Methadone | 21 | $1,269 | $60 |
| Lamotrigine | 31 | $1,237 | $40 |
| Pravastatin | 51 | $1,232 | $24 |
| Estradiol | 12 | $1,208 | $101 |
| Verapamil Sr | 11 | $1,160 | $105 |
| Mirtazapine | 39 | $1,155 | $30 |
| Famotidine | 53 | $1,122 | $21 |
| Rosuvastatin | 22 | $1,100 | $50 |
| Buspirone | 49 | $1,094 | $22 |
| Fluoxetine | 34 | $1,051 | $31 |
| Spironolactone | 26 | $1,047 | $40 |
| Alendronate | 65 | $967 | $15 |
| Insulin Lispro | 11 | $955 | $87 |
| Montelukast | 41 | $946 | $23 |
| Azelastine | 16 | $938 | $59 |
| Simvastatin | 73 | $930 | $13 |
| Ketoconazole | 23 | $871 | $38 |
| Warfarin | 33 | $865 | $26 |
| Trazodone | 90 | $850 | $9 |
| Verapamil Er | 15 | $832 | $55 |
| Hydroxyurea | 17 | $821 | $48 |
| Glipizide Er | 52 | $787 | $15 |
| Bupropion Xl | 33 | $761 | $23 |
| Oxycodone-Acetaminophen | 36 | $757 | $21 |
| Nano 2nd Gen Pen Needle | 13 | $737 | $57 |
| Oxybutynin Chloride Er | 22 | $723 | $33 |
| Hydralazine | 18 | $718 | $40 |
| Metformin | 80 | $676 | $8 |
| Felodipine Er | 13 | $662 | $51 |
| Finasteride | 27 | $660 | $24 |
| Sertraline | 56 | $625 | $11 |
| Furosemide | 93 | $619 | $7 |
| Hydroxyzine | 30 | $594 | $20 |
| Glipizide | 28 | $554 | $20 |
| Allopurinol | 21 | $549 | $26 |
| Isosorbide Mononitrate Er | 20 | $540 | $27 |
| Triamcinolone Acetonide | 47 | $527 | $11 |
| Escitalopram | 41 | $502 | $12 |
| Desmopressin Acetate | 11 | $482 | $44 |
| Amitriptyline | 24 | $449 | $19 |
| Ropinirole | 17 | $446 | $26 |
| Propranolol | 14 | $435 | $31 |
| Digoxin | 11 | $418 | $38 |
| Pregabalin | 14 | $410 | $29 |
| Ipratropium | 11 | $409 | $37 |
| Carvedilol | 33 | $408 | $12 |
| Butalbital-Acetaminophen-Caffe | 11 | $403 | $37 |
| Naproxen | 18 | $379 | $21 |
| Paroxetine | 15 | $374 | $25 |
| Lisinopril-Hydrochlorothiazide | 31 | $371 | $12 |
| Venlafaxine Hcl Er | 14 | $354 | $25 |
| Irbesartan | 13 | $354 | $27 |
| Doxazosin Mesylate | 11 | $336 | $31 |
| Calcitonin-Salmon | 11 | $335 | $30 |
| Benazepril | 23 | $321 | $14 |
| Nitrofurantoin Mono-Macro | 16 | $295 | $18 |
| Hydrochlorothiazide | 49 | $288 | $6 |
| Nystatin | 11 | $257 | $23 |
| Quetiapine | 17 | $255 | $15 |
| Ondansetron | 15 | $247 | $16 |
| Bupropion | 16 | $246 | $15 |
| Vitamin D2 | 27 | $242 | $9 |
| Sotalol | 13 | $236 | $18 |
| Oxycodone | 13 | $235 | $18 |
| Donepezil | 18 | $230 | $13 |
| Quinapril | 20 | $216 | $11 |
| Atenolol | 13 | $190 | $15 |
| Valacyclovir | 13 | $180 | $14 |
| Amoxicillin-Clavulanate Potass | 12 | $168 | $14 |
| Mupirocin | 11 | $161 | $15 |
| Tramadol | 19 | $160 | $8 |
| Citalopram Hbr | 21 | $160 | $8 |
| Sumatriptan | 19 | $151 | $8 |
| Clonazepam | 19 | $135 | $7 |
| Alprazolam | 19 | $118 | $6 |
| Diazepam | 24 | $110 | $5 |
| Folic Acid | 12 | $101 | $8 |
| Prednisone | 12 | $98 | $8 |
| Zolpidem | 25 | $82 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $73 | $6 |
| Azithromycin | 13 | $65 | $5 |
| Lorazepam | 18 | $54 | $3 |
2021: 99 drugs
| Eliquis | 57 | $42,581 | $747 |
| Ozempic | 31 | $30,406 | $981 |
| Januvia | 12 | $18,135 | $1,511 |
| Trulicity | 17 | $15,338 | $902 |
| Rybelsus | 11 | $13,385 | $1,217 |
| Advair Diskus | 20 | $10,141 | $507 |
| Myrbetriq | 15 | $9,731 | $649 |
| Flovent Hfa | 19 | $9,617 | $506 |
| Lantus | 14 | $9,350 | $668 |
| Atrovent Hfa | 14 | $8,536 | $610 |
| Invokana | 11 | $6,511 | $592 |
| Hydrocodone-Acetaminophen | 149 | $4,934 | $33 |
| Diclofenac | 74 | $4,377 | $59 |
| Atorvastatin | 274 | $3,696 | $13 |
| Levothyroxine | 137 | $3,138 | $23 |
| Potassium Chloride | 99 | $2,655 | $27 |
| Gabapentin | 142 | $2,535 | $18 |
| Pantoprazole | 103 | $2,069 | $20 |
| Losartan | 138 | $2,067 | $15 |
| Omeprazole | 86 | $1,842 | $21 |
| Oxycodone-Acetaminophen | 46 | $1,762 | $38 |
| Bumetanide | 25 | $1,746 | $70 |
| Premarin | 11 | $1,734 | $158 |
| Methadone | 37 | $1,705 | $46 |
| Metoprolol | 65 | $1,620 | $25 |
| Duloxetine | 56 | $1,605 | $29 |
| Albuterol Sulfate Hfa | 34 | $1,392 | $41 |
| Buspirone | 36 | $1,384 | $38 |
| Synthroid | 14 | $1,224 | $87 |
| Verapamil Sr | 15 | $1,208 | $81 |
| Amlodipine Besylate | 182 | $1,199 | $7 |
| Fluticasone Propionate | 43 | $1,152 | $27 |
| Lisinopril | 166 | $1,143 | $7 |
| Ventolin Hfa | 12 | $1,123 | $94 |
| Pregabalin | 25 | $1,048 | $42 |
| Triamterene-Hydrochlorothiazid | 49 | $1,032 | $21 |
| Trazodone | 85 | $997 | $12 |
| Tamsulosin | 50 | $919 | $18 |
| Pravastatin | 45 | $878 | $20 |
| Famotidine | 44 | $857 | $19 |
| Hydroxyzine | 48 | $846 | $18 |
| Mirtazapine | 26 | $840 | $32 |
| Nyamyc | 16 | $823 | $51 |
| Oxycodone | 30 | $785 | $26 |
| Ketoconazole | 22 | $778 | $35 |
| Ezetimibe | 17 | $774 | $46 |
| Cyclobenzaprine | 46 | $633 | $14 |
| Nano 2nd Gen Pen Needle | 12 | $584 | $49 |
| Finasteride | 21 | $574 | $27 |
| Simvastatin | 51 | $553 | $11 |
| Sertraline | 41 | $531 | $13 |
| Clonazepam | 39 | $528 | $14 |
| Butalbital-Acetaminophen-Caffe | 14 | $519 | $37 |
| Alendronate | 34 | $515 | $15 |
| Venlafaxine Hcl Er | 13 | $497 | $38 |
| Warfarin | 24 | $497 | $21 |
| Desmopressin Acetate | 12 | $492 | $41 |
| Metformin | 67 | $490 | $7 |
| Spironolactone | 24 | $474 | $20 |
| Fluoxetine | 19 | $457 | $24 |
| Ropinirole | 24 | $456 | $19 |
| Verapamil Er | 12 | $453 | $38 |
| Metformin Hcl Er | 34 | $448 | $13 |
| Prazosin | 11 | $445 | $40 |
| Escitalopram | 49 | $444 | $9 |
| Clopidogrel | 29 | $439 | $15 |
| Nitrofurantoin Mono-Macro | 20 | $407 | $20 |
| Isosorbide Mononitrate Er | 14 | $401 | $29 |
| Metoprolol | 45 | $397 | $9 |
| Montelukast | 29 | $395 | $14 |
| Memantine | 13 | $393 | $30 |
| Glipizide Er | 32 | $390 | $12 |
| Aripiprazole | 23 | $381 | $17 |
| Paroxetine | 17 | $370 | $22 |
| Doxazosin Mesylate | 16 | $338 | $21 |
| Furosemide | 48 | $332 | $7 |
| Triamcinolone Acetonide | 36 | $328 | $9 |
| Hydrochlorothiazide | 60 | $307 | $5 |
| Alprazolam | 35 | $278 | $8 |
| Carvedilol | 16 | $238 | $15 |
| Tramadol | 23 | $238 | $10 |
| Amitriptyline | 13 | $224 | $17 |
| Rizatriptan | 13 | $222 | $17 |
| Donepezil | 19 | $220 | $12 |
| Atenolol | 13 | $217 | $17 |
| Quinapril | 14 | $212 | $15 |
| Glipizide | 28 | $206 | $7 |
| Vitamin D2 | 25 | $196 | $8 |
| Lisinopril-Hydrochlorothiazide | 23 | $193 | $8 |
| Acetaminophen-Codeine | 20 | $190 | $10 |
| Acyclovir | 15 | $155 | $10 |
| Citalopram Hbr | 21 | $144 | $7 |
| Temazepam | 14 | $133 | $9 |
| Diazepam | 17 | $99 | $6 |
| Zolpidem | 28 | $95 | $3 |
| Prednisone | 19 | $89 | $5 |
| Sumatriptan | 17 | $79 | $5 |
| Lorazepam | 27 | $77 | $3 |
| Sulfamethoxazole-Trimethoprim | 17 | $51 | $3 |
2020: 6 drugs
| Diclofenac | 18 | $1,103 | $61 |
| Atorvastatin | 25 | $340 | $14 |
| Hydrocodone-Acetaminophen | 12 | $296 | $25 |
| Pantoprazole | 12 | $234 | $19 |
| Gabapentin | 12 | $211 | $18 |
| Lisinopril | 21 | $99 | $5 |
Money from drug and device companies
$32 in 2025
| 2025 | 1 | 1 | None | $32 |
| 2024 | 1 | 1 | None | $50 |
| 2023 | 3 | 3 | None | $321 |
| 2022 | 3 | 5 | None | $481 |
| 2021 | 1 | 3 | None | $281 |
| 2020 | 1 | 1 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $32 | 1 payment
|
See the published payment
| Novo Nordisk | Education · 2025-02-07 | Ozempic | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $50
| Trice Medical | None | $50 | 1 payment
|
2023: $321
| Regeneron Healthcare Solutions | Dupixent | $123 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $102 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $97 | 1 payment
|
2022: $481
| Novo Nordisk | Rybelsus | $253 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $130 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $99 | 1 payment
|
2021: $281
| Novo Nordisk | Rybelsus | $281 | 3 payments
|
2020: $120
| Pfizer | Eliquis | $120 | 1 payment
|
Professional record
- NPI
- 1225569726
- Licence
- CA A166906California A166906: Current · expires 2027-11-30
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2017-03-25
- NPI last updated
- 2026-03-20
- NPI record certified
- 2026-03-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2734 El Camino Real, Santa Clara, CA, 95051